Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04003636 |
|---|---|
| Brief Title: | Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966) (KEYNOTE-966) |
| First Submitted : | June 28, 2019 |
| First Submitted that Met QC Criteria : | June 28, 2019 |
| First Posted : | July 1, 2019 |
| Results First Submitted : | December 6, 2023 |
| Results First Submitted that Met QC Criteria : | December 6, 2023 |
| Results First Posted : | December 22, 2023 |
| Last Update Submitted that Met QC Criteria : | March 4, 2024 |
| Last Update Posted : | March 5, 2024 |